OTCQB Application Submitted

Valereum PLC
05 June 2024


The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")



Valereum Plc

("Valereum" or the "Company")


OTCQB Application Submitted


Valereum Plc (AQSE: VLRM) is pleased to announce that an application has been filed with the OTC Markets Group for the Company's ordinary shares to be publicly cross traded on the OTCQB Market based in the United States, which upon approval, would make Valereum's shares more widely available to North American investors. This aligns with the Company's aims to deliver shareholder value and increase the business footprint globally.


The directors of the Company accept responsibility for the contents of this announcement.


For more information, please visit the Company's website at www.vlrm.com


For further information, please contact:


Valereum Plc   

James Formolli, Chairman    

Tel: +971 4584 6284   


Stanford Capital Partners           

Tel: 023 3650 3650

Bob Pountney

Patrick Claridge


AQSE Corporate Adviser   

First Sentinel Corporate Finance    

Brian Stockbridge    

Tel: +44 20 3855 5551  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
UK 100

Latest directors dealings